Adalimumab-Aqvh
2 NDCs across 2 manufacturers|0 Generic,2 Brand
Adalimumab-Aqvh is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $650K on Adalimumab-Aqvh across 549 claims for 98 beneficiaries.
Adalimumab-Aqvh is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $604.15 to $604.15 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
2
competing in market
Price Spread
$604.15 – $604.15
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing ADALIMUMAB-AQVH
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
YUSIMRY(CF) 40 MG/0.8 ML PEN | $604.1525 per ML | — |
YUSIMRY(CF) 40 MG/0.8 ML PEN | $604.1525 per ML | — |
Frequently Asked Questions
What is Adalimumab-Aqvh used to treat?
Adalimumab-Aqvh is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Aqvh?
In 2024, Medicare Part D spent $650K on Adalimumab-Aqvh across 549 claims for 98 beneficiaries.
How many Adalimumab-Aqvh products are on the market?
The Adalimumab-Aqvh drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.
What is the price range for Adalimumab-Aqvh?
NADAC reference prices for Adalimumab-Aqvh range from $604.1525 to $604.1525 per ML.
Which manufacturers make Adalimumab-Aqvh?
2 manufacturers list Adalimumab-Aqvh in NADAC. Ranked by number of NDCs, the largest are Meitheal Pharmaceuticals Inc. (1), Coherus BioSciences Inc (1).